BR9608897A -
DNA fusion polypeptide construction of recombinant dna cell transformed with the fungal or mammalian plant dna process to select compounds capable of being linked to a member of the selected compound insect steroid receptor superfamily using said agricultural or pharmaceutical composition process use of the compound peptide process or polypeptide
- Google Patents
DNA fusion polypeptide construction of recombinant dna cell transformed with the fungal or mammalian plant dna process to select compounds capable of being linked to a member of the selected compound insect steroid receptor superfamily using said agricultural or pharmaceutical composition process use of the compound peptide process or polypeptide
Info
Publication number
BR9608897A
BR9608897ABR9608897ABR9608897ABR9608897ABR 9608897 ABR9608897 ABR 9608897ABR 9608897 ABR9608897 ABR 9608897ABR 9608897 ABR9608897 ABR 9608897ABR 9608897 ABR9608897 ABR 9608897A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9510759.5Aexternal-prioritypatent/GB9510759D0/en
Priority claimed from GBGB9513882.2Aexternal-prioritypatent/GB9513882D0/en
Priority claimed from GBGB9517316.7Aexternal-prioritypatent/GB9517316D0/en
Application filed by Zeneca LtdfiledCriticalZeneca Ltd
Priority claimed from PCT/GB1996/001195external-prioritypatent/WO1996037609A1/en
Publication of BR9608897ApublicationCriticalpatent/BR9608897A/en
BR9608897A1995-05-261996-05-20
DNA fusion polypeptide construction of recombinant dna cell transformed with the fungal or mammalian plant dna process to select compounds capable of being linked to a member of the selected compound insect steroid receptor superfamily using said agricultural or pharmaceutical composition process use of the compound peptide process or polypeptide
BR9608897A
(en)
DNA fusion polypeptide construction of recombinant dna cell transformed with the fungal or mammalian plant dna process to select compounds capable of being linked to a member of the selected compound insect steroid receptor superfamily using said agricultural or pharmaceutical composition process use of the compound peptide process or polypeptide
Polynucleotide and purified polypeptide in the host cell vector processes to produce mdc to produce an mdc polypeptide analog to modulate leukocyte chemotaxis in a mammalian host to alleviate an inflammatory cleavage in a patient and to identify an anti-hybridoma cell line antibody chemical compound polyclonal serum and pharmaceutical composition and use of the composition
DNA fusion polypeptide construction of recombinant dna cell transformed with the fungal or mammalian plant dna process to select compounds capable of being linked to a member of the selected compound insect steroid receptor superfamily using said agricultural or pharmaceutical composition process use of the compound peptide process or polypeptide
Structure–function studies on hypertrehalosaemic and adipokinetic hormones: activity of naturally occurring analogues and some N‐and C‐terminal modified analogues
Pharmaceutical composition use of an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide and product containing an amount of (i) a standardized antigen together with an amount of (ii) a polypeptide
Derived from 2-(0-(pyrimidin)-4-yl)-phenyl-acetic acid or a salt or n-oxide thereof and use of the same composition suitable for the control of harmful fungi and animal pests and processes for its preparation and for control of harmful fungi and animal pests